AIM-MAX MEDICAL ApS Financials, key figures and credit report
Gross profit 231.8 kDKK FY 2025 +34.2% vs 2024
EBIT 28.4 kDKK FY 2025 +62.8% vs 2024
Net debt - 223.7 kDKK FY 2025 -27.2% vs 2024
Quick ratio 1.7 FY 2025 +0.3 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 261.26 | 305.88 | 265.63 | 172.71 | 231.82 |
| Employee benefit expenses | - 179.55 | - 215.01 | - 202.91 | - 155.24 | - 203.38 |
| EBIT | 81.71 | 90.87 | 62.72 | 17.47 | 28.45 |
| Other financial income | 1.95 | 0.07 | |||
| Other financial expenses | -6.46 | -6.46 | -3.30 | -6.92 | -24.70 |
| Pre-tax profit | 75.25 | 84.41 | 59.42 | 12.50 | 3.81 |
| Income taxes | -17.38 | -19.40 | -13.83 | -46.79 | 37.80 |
| Net earnings | 57.87 | 65.01 | 45.60 | -34.29 | 41.61 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Finished products/goods | 1 757.00 | 1 711.00 | 2 167.07 | 1 941.80 | 1 910.72 |
| Inventories total | 1 757.00 | 1 711.00 | 2 167.07 | 1 941.80 | 1 910.72 |
| Current trade debtors | 494.00 | 438.00 | 352.05 | 469.44 | 396.13 |
| Prepayments and accrued income | 24.00 | 23.00 | 22.80 | 0.78 | |
| Current other receivables | 1.00 | 38.00 | 36.53 | ||
| Current deferred tax assets | 1.84 | ||||
| Short term receivables total | 519.00 | 499.00 | 411.38 | 470.22 | 397.97 |
| Cash and bank deposits | 425.00 | 535.00 | 105.53 | 186.95 | 234.28 |
| Cash and cash equivalents | 425.00 | 535.00 | 105.53 | 186.95 | 234.28 |
| Balance sheet total (assets) | 2 701.00 | 2 745.00 | 2 683.99 | 2 598.97 | 2 542.98 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 |
| Retained earnings | 1 861.13 | 1 917.99 | 1 983.43 | 2 029.03 | 1 994.74 |
| Profit of the financial year | 57.87 | 65.01 | 45.60 | -34.29 | 41.61 |
| Shareholders equity total | 2 044.00 | 2 108.00 | 2 154.03 | 2 119.74 | 2 161.34 |
| Non-current liabilities total | |||||
| Current loans from credit institutions | 10.20 | ||||
| Advances received | 117.00 | ||||
| Current trade creditors | 277.00 | 238.00 | 291.67 | 174.47 | 164.33 |
| Current owed to participating | 38.17 | 11.12 | 0.42 | ||
| Short-term deferred tax liabilities | 9.00 | 15.00 | 9.83 | 40.79 | |
| Other non-interest bearing current liabilities | 254.00 | 384.00 | 190.28 | 252.85 | 206.68 |
| Current liabilities total | 657.00 | 637.00 | 529.96 | 479.23 | 381.63 |
| Balance sheet total (liabilities) | 2 701.00 | 2 745.00 | 2 683.99 | 2 598.97 | 2 542.98 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated